# A Study of Envafolimab in Subjects With Stage III Non-Small Cell Lung Cancer

> **NCT05414630** · PHASE2 · UNKNOWN · sponsor: **Anhui Provincial Cancer Hospital** · enrollment: 30 (estimated)

## Conditions studied

- Non-small Cell Lung Cancer Stage III

## Interventions

- **DRUG:** Envafolimab

## Key facts

- **NCT ID:** NCT05414630
- **Lead sponsor:** Anhui Provincial Cancer Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-06
- **Primary completion:** 2024-06
- **Final completion:** 2025-06
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2022-06-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05414630

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05414630, "A Study of Envafolimab in Subjects With Stage III Non-Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05414630. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*